Literature DB >> 33070450

Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis.

Li-Na Zhang1, Di-Di Zhang1, Lei Yang1, Yu-Xuan Gu1, Qiu-Ping Zuo1, Hao-Yi Wang1, Jia Xu1, Dian-Xin Liu1.   

Abstract

Invasion and metastasis are the basic characteristics and important markers of malignant tumors, which are also the main cause of death in cancer patients. Epithelial-mesenchymal transition (EMT) is recognized as the first step of tumor invasion and metastasis. Many studies have demonstrated that cell fusion is a common phenomenon and plays a critical role in cancer development and progression. At present, cancer stem cell fusion has been considered as a new mechanism of cancer metastasis. Mesenchymal stromal/stem cell (MSC) is a kind of adult stem cells with high self-renewal ability and multidifferentiation potential, which is used as a very promising fusogenic candidate in the tumor microenvironment and has a crucial role in cancer progression. Many research results have shown that MSCs are involved in the regulation of tumor growth and metastasis through cell fusion. However, the role of cell fusion between MSCs and malignant cells in tumor growth and metastasis is still controversial. Several studies have demonstrated that MSCs can enhance malignant characteristics, promoting tumor growth and metastasis by fusing with malignant cells, while other conflicting reports believe that MSCs can reduce tumorigenicity upon fusion with malignant cells. In this review, we summarize the recent research on cell fusion events between MSCs and malignant cells in tumor growth and metastasis. The elucidation of the molecular mechanisms between MSC fusion and tumor metastasis may provide an effective strategy for tumor biotherapy.
© 2020 Federation of European Biochemical Societies.

Entities:  

Keywords:  cancer stem/initiating cells; cell fusion; epithelial-mesenchymal transition; mesenchymal stromal/stem cells; tumor metastasis

Year:  2020        PMID: 33070450     DOI: 10.1111/febs.15483

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  2 in total

Review 1.  Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke.

Authors:  Yuchen Zhang; Naijun Dong; Huanle Hong; Jingxuan Qi; Shibo Zhang; Jiao Wang
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

2.  Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway.

Authors:  Jiachen Duan; Mengyuan Jin; Dongjing Yang; Jihua Shi; Jie Gao; Danfeng Guo; Hongwei Tang; Shuijun Zhang; Baoping Qiao
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.